文献速递类风湿关节炎

靶向非经典NF-κB通路抑制类风湿关节炎滑膜血管生成的新三维模型

Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis.
PubMed 文献 · Rheumatology (Oxford) · 2016-11-17

该研究建立了一种包含内皮细胞、类风湿关节炎成纤维样滑膜细胞和类风湿关节炎滑液的三维滑膜血管生成模型,用于研究非经典NF-κB通路的作用。结果显示滑液可显著促进血管出芽,LTβR配体及bFGF/VEGF亦可诱导出芽;siNIK、LTβR-Ig融合蛋白(baminercept)及新型NIK抑制剂均可抑制相关血管生成,提示该通路具有治疗潜力。

要点

  • RASF可显著促进三维模型中内皮细胞出芽,该效应可被anginex阻断。
  • LTβ、LIGHT及bFGF/VEGF均诱导显著出芽,LTβR-Ig还可阻断RASF诱导的出芽。
  • NIK抑制剂可阻断LTβ、LIGHT、生长因子及RASF诱导的血管生成。

核心结论

  • 非经典NF-κB信号通路促进滑膜新生血管形成,靶向该通路(如NIK抑制或LTβR-Ig)在该三维模型中可抑制血管生成。

研究设计与样本

  • 研究采用由RAFLS与内皮细胞构成的球状体,经RASF、LTβR配体LTβ和LIGHT或生长因子bFGF、VEGF刺激,用共聚焦显微镜与数字图像分析定量内皮出芽。
  • 进一步评估anginex、NIK靶向siRNA(siNIK)、LTβR-Ig融合蛋白(baminercept)及新型药理学NIK抑制剂的作用。

主要发现

  • RASF显著促进出芽形成,并被已建立的血管生成抑制剂anginex阻断(P < 0.05)。
  • LTβ和LIGHT诱导显著出芽(P < 0.05),bFGF/VEGF亦诱导显著出芽(P < 0.01)。
  • 内皮细胞经siNIK预处理后LTβR诱导的血管形成减少(P < 0.05)。
  • LTβR-Ig不仅阻断LTβ或LIGHT诱导的出芽,也阻断RASF诱导的出芽(P < 0.05)。
  • NIK抑制剂阻断LTβ、LIGHT、生长因子诱导的血管生成(P < 0.05)及RASF诱导的血管生成(P < 0.01)。

关键数值与推荐

  • RASF促进出芽且anginex阻断:P < 0.05。
  • LTβ、LIGHT诱导出芽:P < 0.05;bFGF/VEGF诱导出芽:P < 0.01。
  • siNIK减少LTβR诱导血管形成:P < 0.05;LTβR-Ig阻断LTβ、LIGHT或RASF诱导出芽:P < 0.05。
  • NIK抑制剂阻断LTβ、LIGHT、生长因子诱导血管生成:P < 0.05;阻断RASF诱导血管生成:P < 0.01。

临床怎么用

  • 该三维模型可用于剖析特定细胞类型中信号通路对血管生成反应的相对贡献,并用于测试血管生成药理学抑制剂。
  • 结果支持非经典NF-κB通路(经NIK)作为RA滑膜新生血管形成的潜在治疗靶点,但尚属体外模型证据。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Angiogenesis is crucial in RA disease progression. Lymphotoxin β receptor (LTβR)-induced activation of the non-canonical nuclear factor-κB (NF-κB) pathway via NF-κB-inducing kinase (NIK) has been implicated in this process. Consequently, inhibition of this pathway may hold therapeutic potential in RA. We describe a novel three-dimensional (3D) model of synovial angiogenesis incorporating endothelial cells (ECs), RA fibroblast-like synoviocytes (RAFLSs) and RA synovial fluid (RASF) to further investigate the contributions of NF-κB in this process. METHODS: Spheroids consisting of RAFLSs and ECs were stimulated with RASF, the LTβR ligands LTβ and LIGHT, or growth factor bFGF and VEGF, followed by quantification of EC sprouting using confocal microscopy and digital image analysis. Next, the effects of anginex, NIK-targeting siRNA (siNIK), LTβR-Ig fusion protein (baminercept) and a novel pharmacological NIK inhibitor were investigated. RESULTS: RASF significantly promoted sprout formation, which was blocked by the established angiogenesis inhibitor anginex (P < 0.05). LTβ and LIGHT induced significant sprouting (P < 0.05), as did bFGF/VEGF (P < 0.01). siNIK pre-treatment of ECs led to reductions in LTβR-induced vessel formation (P < 0.05). LTβR-Ig not only blocked LTβ- or LIGHT-induced sprouting, but also RASF-induced sprouting (P < 0.05). The NIK inhibitor blocked angiogenesis induced by LTβ, LIGHT, growth factors (P < 0.05) and RASF (P < 0.01). CONCLUSION: We present a novel 3D model of synovial angiogenesis incorporating RAFLSs, ECs and RASF that mimics the in vivo situation. Using this system, we demonstrate that non-canonical NF-κB signalling promotes neovascularization and show that this model is useful for dissecting relative contributions of signalling pathways in specific cell types to angiogenic responses and for testing pharmacological inhibitors of angiogenesis.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Maracle CX, Kucharzewska P, Helder B, et al. Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis. Rheumatology (Oxford). 2016. PMID: 27864565. doi:10.1093/rheumatology/kew393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。